NYSE · Health Information Services · USD
Claritev Corporation (CTEV) Stock Analysis
Claritev Corporation (CTEV) is a Health Information Services stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CTEV Key Statistics
As of Oct 21, 2026Trading
- Open
- $22.58
- Previous Close
- $22.39
- Day's Range
- 22.59–23.09
- 52-Week Range
- 11.50–73.68
- Volume
- 117.64K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.94
Valuation
- Market Cap
- $389.79M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 3.14
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.39
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −17.00
Financials (FY)
- Revenue (FY)
- $965.41M+3.74%
- Net Income (FY)
- −$284.28M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −28.46%
- Shares Outstanding
- 16.95M
- 1-Year Return
- −65.15%
Dividend and dates
- Earnings Date
- November 9, 2026
- Avg Volume
- 142.80K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CTEV closed at $23.00, −65.15% over 1 year.
Claritev Corporation (CTEV) has a market capitalization of $389.79M.
In fiscal 2025, CTEV reported revenue of $965.41M.
CTEV Stock Return by Calendar Year
Claritev Corporation (CTEV) return since Apr 2020: what $10,000 became
- 1 year
- $10,000 $3,485
- −65.15%
- 5 years
- $10,000 $1,127
- −88.73%
- Since Apr 2020
- $10,000 $592
- −94.08%
If you had invested $10,000 in Claritev Corporation (CTEV) at the close on April 3, 2020, the earliest close on record here, it would have been worth $592 at the close on October 21, 2026: −94.08% in total, −35.06% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −46.20% |
| 2025 | +189.24% |
| 2024 | −74.34% |
| 2023 | +25.22% |
| 2022 | −74.04% |
| 2021 | −44.56% |
| 2020 (partial year) | −17.80% |
As of October 21, 2026.
CTEV Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $965.41M | −$284.28M | −29.4% |
| 2024 | $930.62M | −$1.65B | −176.9% |
| 2023 | $961.52M | −$91.70M | −9.5% |
| 2022 | $1.08B | −$572.91M | −53.1% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $965.41M | $649.05M | $45.06M | −$284.28M | −29.4% |
| 2024 | $930.62M | $627.17M | $108.26M | −$1.65B | −176.9% |
| 2023 | $961.52M | $665.90M | $170.92M | −$91.70M | −9.5% |
| 2022 | $1.08B | $875.62M | $334.18M | −$572.91M | −53.1% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CTEV Valuation vs Health Information Services Median
Median of 44 stocks| Metric | CTEV | Health Information Services median | vs median |
|---|---|---|---|
| P/S ratio | 0.39 | 2.31 | 0.2x the median |
| Profit margin | −28.46% | −7.55% | 20.9 pts below |
Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Claritev Appoints Jennifer Main to its Board of Directors
YahooClaritev Corporation Announces Third Quarter 2026 Earnings Conference Call
YahooClaritev: Revenue Growth Is Back, Cash Flow Is The Next Test
SeekingAlphaClaritev Selected by GDIT to Support CDC’s World Trade Center Health Program
YahooClaritev Selected By General Dynamics Information Technology To Support The World Trade Center Health Program; Terms Not Disclosed
BenzingaClaritev Releases 2025 Corporate Responsibility Report
Yahoo
All 20 articles ↓Show fewer ↑
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
SeekingAlphaClaritev Appoints Ben Letham to its Board of Directors
YahooClaritev Cares Helps Rural Patients Get Critical Care Closer to Home
YahooClaritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks
YahooClaritev (CTEV) Price Target Increased by 21.68% to 46.75
FintelBarclays Maintains Overweight on Claritev, Raises Price Target to $40
BenzingaClaritev Expands Collaboration With Marpai To Launch Pre, Post- Payment Integrity Services To Health Plans
BenzingaWells Fargo Maintains Equal-Weight on Claritev, Raises Price Target to $30
BenzingaClaritev Analysts Raise Their Forecasts Following Q2 Earnings
BenzingaCitigroup Maintains Buy on Claritev, Raises Price Target to $45
BenzingaCanaccord Genuity Maintains Buy on Claritev, Raises Price Target to $43
BenzingaClaritev Q2 Earnings Call Highlights
MarketBeatClaritev Corporation 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaClaritev Corp (CTEV) (Q2 2026) Earnings Call Highlights: Record Bookings and AI-Driven Growth ...
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$51.90B
BTSGBrightSpring Health Services, Inc.
$12.40B
TEMTempus AI, Inc.
$12.23B
HNGEHinge Health, Inc.
$9.04B
HQYHealthEquity, Inc.
$8.10B
DOCSDoximity, Inc.
$5.99B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B













